{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:49:46Z","timestamp":1771379386534,"version":"3.50.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Western Norway Regional Health Authority","award":["911701"],"award-info":[{"award-number":["911701"]}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["213704"],"award-info":[{"award-number":["213704"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,24]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Autoimmune Addison's disease (AAD) is caused by selective destruction of the hormone-producing cells of the adrenal cortex. As yet, little is known about the potential role played by environmental factors in this process. Type I and\/or type III interferons (IFNs) are signature responses to virus infections, and have also been implicated in the pathogenesis of autoimmune endocrine disorders such as type 1 diabetes and autoimmune thyroiditis. Transient development of AAD and exacerbation of established or subclinical disease, as well as the induction of autoantibodies associated with AAD, have been reported following therapeutic administration of type I IFNs. We therefore hypothesize that exposure to such IFNs could render the adrenal cortex susceptible to autoimmune attack in genetically predisposed individuals. In this study, we investigated possible immunopathological effects of type I and type III IFNs on adrenocortical cells in relation to AAD. Both types I and III IFNs exerted significant cytotoxicity on NCI-H295R adrenocortical carcinoma cells and potentiated IFN-\u03b3- and polyinosine-polycytidylic acid [poly (I\u2009:\u2009C)]-induced chemokine secretion. Furthermore, we observed increased expression of human leucocyte antigen (HLA) class I molecules and up-regulation of 21-hydroxylase, the primary antigenic target in AAD. We propose that these combined effects could serve to initiate or aggravate an ongoing autoimmune response against the adrenal cortex in AAD.<\/jats:p>","DOI":"10.1111\/cei.12291","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T11:22:33Z","timestamp":1392636153000},"page":"351-362","source":"Crossref","is-referenced-by-count":12,"title":["The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease"],"prefix":"10.1093","volume":"176","author":[{"given":"A","family":"Hellesen","sequence":"first","affiliation":[{"name":"Section for Endocrinology, Department of Clinical Science, University of Bergen, Bergen, Norway"},{"name":"Department of Medicine, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Edvardsen","sequence":"additional","affiliation":[{"name":"Section for Endocrinology, Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Breivik","sequence":"additional","affiliation":[{"name":"Section for Endocrinology, Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E S","family":"Husebye","sequence":"additional","affiliation":[{"name":"Section for Endocrinology, Department of Clinical Science, University of Bergen, Bergen, Norway"},{"name":"Department of Medicine, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8359-9818","authenticated-orcid":false,"given":"E","family":"Bratland","sequence":"additional","affiliation":[{"name":"Section for Endocrinology, Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"2021122010035940200_cei12291-bib-0001","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122010035940200_cei12291-bib-0002","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison's disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"key":"2021122010035940200_cei12291-bib-0003","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1210\/jc.2009-1115","article-title":"T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency","volume":"94","author":"Bratland","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122010035940200_cei12291-bib-0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaut.2010.07.001","article-title":"21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease","volume":"35","author":"Rottembourg","year":"2010","journal-title":"J Autoimmun"},{"key":"2021122010035940200_cei12291-bib-0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mce.2010.12.015","article-title":"Cellular immunity and immunopathology in autoimmune Addison's disease","volume":"336","author":"Bratland","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0006","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein\u2013Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"key":"2021122010035940200_cei12291-bib-0007","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1086\/315516","article-title":"Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection","volume":"181","author":"Chehadeh","year":"2000","journal-title":"J Infect Dis"},{"key":"2021122010035940200_cei12291-bib-0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C","volume":"117","author":"Antonelli","year":"2004","journal-title":"Am J Med"},{"key":"2021122010035940200_cei12291-bib-0009","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"Doyle","year":"2006","journal-title":"Hepatology"},{"key":"2021122010035940200_cei12291-bib-0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"2021122010035940200_cei12291-bib-0011","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"2021122010035940200_cei12291-bib-0012","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/viro.1996.0259","article-title":"When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA","volume":"219","author":"Jacobs","year":"1996","journal-title":"Virology"},{"key":"2021122010035940200_cei12291-bib-0013","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/eji.200324610","article-title":"Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells","volume":"34","author":"Coccia","year":"2004","journal-title":"Eur J Immunol"},{"key":"2021122010035940200_cei12291-bib-0014","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2021122010035940200_cei12291-bib-0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Antonelli","year":"2010","journal-title":"Cytokine"},{"key":"2021122010035940200_cei12291-bib-0016","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1210\/jc.2006-0620","article-title":"Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth","volume":"91","author":"van Koetsveld","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122010035940200_cei12291-bib-0017","first-page":"1821","article-title":"Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL\/Apo2L induction in melanoma cell lines","volume":"7","author":"Chawla-Sarkar","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2021122010035940200_cei12291-bib-0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"2021122010035940200_cei12291-bib-0019","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2184.2008.00558.x","article-title":"Regulation of apoptosis by type III interferons","volume":"41","author":"Li","year":"2008","journal-title":"Cell Prolif"},{"key":"2021122010035940200_cei12291-bib-0020","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021122010035940200_cei12291-bib-0021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.gene.6364324","article-title":"A subtype of multiple sclerosis defined by an activated immune defense program","volume":"7","author":"van Baarsen","year":"2006","journal-title":"Genes Immun"},{"key":"2021122010035940200_cei12291-bib-0022","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1073\/pnas.0806439105","article-title":"Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122010035940200_cei12291-bib-0023","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","article-title":"IFN-alpha mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms","volume":"186","author":"Akeno","year":"2011","journal-title":"J Immunol"},{"key":"2021122010035940200_cei12291-bib-0024","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.23.8.1177","article-title":"Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection","volume":"23","author":"Betterle","year":"2000","journal-title":"Diabetes Care"},{"key":"2021122010035940200_cei12291-bib-0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet"},{"key":"2021122010035940200_cei12291-bib-0026","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.48.3.378","article-title":"Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C","volume":"48","author":"Wesche","year":"2001","journal-title":"Gut"},{"key":"2021122010035940200_cei12291-bib-0027","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.diabres.2009.08.009","article-title":"Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C","volume":"86","author":"Hayashi","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"2021122010035940200_cei12291-bib-0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2169\/internalmedicine.49.2656","article-title":"Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C","volume":"49","author":"Yamazaki","year":"2010","journal-title":"Intern Med"},{"key":"2021122010035940200_cei12291-bib-0029","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MAJ.0b013e31820ff7af","article-title":"Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha","volume":"341","author":"Krysiak","year":"2011","journal-title":"Am J Med Sci"},{"key":"2021122010035940200_cei12291-bib-0030","first-page":"511","article-title":"[A case of Addison's disease which became worse during interferon therapy: insulin secretion under hyposmolarity]","volume":"70","author":"Oshimoto","year":"1994","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"key":"2021122010035940200_cei12291-bib-0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1757-1626-1-157","article-title":"Exacerbation of hepatitis C induced subclinical hypoadrenalism by interferon-alpha2beta: a case report","volume":"1","author":"Tran","year":"2008","journal-title":"Cases J"},{"key":"2021122010035940200_cei12291-bib-0032","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(81)91522-1","article-title":"Increased steroid dependence after recombinant leucocyte interferon therapy","volume":"2","author":"Knost","year":"1981","journal-title":"Lancet"},{"key":"2021122010035940200_cei12291-bib-0033","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijid.2005.08.001","article-title":"Adrenal infections","volume":"10","author":"Paolo","year":"2006","journal-title":"Int J Infect Dis"},{"key":"2021122010035940200_cei12291-bib-0034","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2012.09.004","article-title":"Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3","volume":"365","author":"Bratland","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2009.02.018","article-title":"The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease","volume":"33","author":"Bratland","year":"2009","journal-title":"J Autoimmun"},{"key":"2021122010035940200_cei12291-bib-0036","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1172\/JCI116835","article-title":"Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients","volume":"92","author":"Itoh","year":"1993","journal-title":"J Clin Invest"},{"key":"2021122010035940200_cei12291-bib-0037","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-10-0960","article-title":"Upregulation of thyroid transcription factor-1 and human leukocyte antigen class I in Hashimoto's disease providing a clinical evidence for possible triggering autoimmune reaction","volume":"164","author":"Huang","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0038","first-page":"a007658","article-title":"Islet autoantigens: structure, function, localization, and regulation","volume":"2","author":"Arvan","year":"2012","journal-title":"Cold Spring Harbour Perspect Med"},{"key":"2021122010035940200_cei12291-bib-0039","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1210\/jc.2004-1062","article-title":"Elevated serum interferon-gamma-inducible chemokine-10\/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines","volume":"90","author":"Rotondi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122010035940200_cei12291-bib-0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/er.2006-0044","article-title":"Role of chemokines in endocrine autoimmune diseases","volume":"28","author":"Rotondi","year":"2007","journal-title":"Endocr Rev"},{"key":"2021122010035940200_cei12291-bib-0041","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2008.10.028","article-title":"Differential expression and action of Toll-like receptors in human adrenocortical cells","volume":"300","author":"Kanczkowski","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0042","first-page":"374","article-title":"Coexistence of Cushing syndrome from functional adrenal adenoma and Addison disease from immune-mediated adrenalitis","volume":"112","author":"Colucci","year":"2012","journal-title":"J Am Osteopath Assoc"},{"key":"2021122010035940200_cei12291-bib-0043","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1210\/jcem.84.5.5631","article-title":"Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs","volume":"84","author":"Bornstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122010035940200_cei12291-bib-0044","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/adc.32.162.120","article-title":"Adrenal necrosis in generalized herpes simplex","volume":"32","author":"Brain","year":"1957","journal-title":"Arch Dis Child"},{"key":"2021122010035940200_cei12291-bib-0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF02467365","article-title":"Adrenocortical insufficiency associated with Epstein\u2013Barr virus infection in a patient with the Wiskott\u2013Aldrich syndrome","volume":"146","author":"Hertel","year":"1987","journal-title":"Eur J Pediatr"},{"key":"2021122010035940200_cei12291-bib-0046","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(05)65385-8","article-title":"Autoimmune hepatitis and adrenal insufficiency in an infant with human herpesvirus-6 infection","volume":"348","author":"Schmitt","year":"1996","journal-title":"Lancet"},{"key":"2021122010035940200_cei12291-bib-0047","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2230.2010.03946.x","article-title":"A black tongue in a young woman","volume":"36","author":"Guinovart","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"2021122010035940200_cei12291-bib-0048","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J Exp Med"},{"key":"2021122010035940200_cei12291-bib-0049","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/endo.143.4.8737","article-title":"Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus","volume":"143","author":"Liu","year":"2002","journal-title":"Endocrinology"},{"key":"2021122010035940200_cei12291-bib-0050","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.1.6127.1591-a","article-title":"Malignant disease presenting as Addison's disease","volume":"1","author":"Rosenthal","year":"1978","journal-title":"BMJ"},{"key":"2021122010035940200_cei12291-bib-0051","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mce.2010.11.012","article-title":"Adrenocortical stem and progenitor cells: unifying model of two proposed origins","volume":"336","author":"Wood","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0052","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.150.11.5185","article-title":"Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha","volume":"150","author":"Ohashi","year":"1993","journal-title":"J Immunol"},{"key":"2021122010035940200_cei12291-bib-0053","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM198508083130604","article-title":"In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis","volume":"313","author":"Bottazzo","year":"1985","journal-title":"N Engl J Med"},{"key":"2021122010035940200_cei12291-bib-0054","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(87)91128-7","article-title":"Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus","volume":"2","author":"Foulis","year":"1987","journal-title":"Lancet"},{"key":"2021122010035940200_cei12291-bib-0055","doi-asserted-by":"crossref","first-page":"31168","DOI":"10.1074\/jbc.M111.247510","article-title":"Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism","volume":"286","author":"Stefan","year":"2011","journal-title":"J Biol Chem"},{"key":"2021122010035940200_cei12291-bib-0056","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jcp.21727","article-title":"Investigation on human adrenocortical cell response to adenovirus and adenoviral vector infection","volume":"220","author":"Matkovic","year":"2009","journal-title":"J Cell Physiol"},{"key":"2021122010035940200_cei12291-bib-0057","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/JME-10-0006","article-title":"ACTH is a potent regulator of gene expression in human adrenal cells","volume":"45","author":"Xing","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0058","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"2021122010035940200_cei12291-bib-0059","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J Clin Invest"},{"key":"2021122010035940200_cei12291-bib-0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process","volume":"154","author":"Antonelli","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2021122010035940200_cei12291-bib-0061","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.24.3.510","article-title":"Elevated serum IP-10 levels observed in type 1 diabetes","volume":"24","author":"Shimada","year":"2001","journal-title":"Diabetes Care"},{"key":"2021122010035940200_cei12291-bib-0062","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1507\/endocrj.K10E-076","article-title":"Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes","volume":"57","author":"Uno","year":"2010","journal-title":"Endocr J"},{"key":"2021122010035940200_cei12291-bib-0063","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","article-title":"Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes","volume":"86","author":"Garcia-Lopez","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12291","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12291","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/176\/3\/351\/41789765\/cei12291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/176\/3\/351\/41789765\/cei12291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:15:28Z","timestamp":1688998528000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/176\/3\/351\/6421174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,4,24]]},"published-print":{"date-parts":[[2014,4,24]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12291","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,6]]},"published":{"date-parts":[[2014,4,24]]}}}